AI Science Tracker
EN

School of Clinical Medicine

1 discovery from 2025

Discoveries

Identification of CDK2 as a key apoptotic gene for predicting cervical cancer prognosis using bioinformatics and machine learning.

Source check: Source checked. Not independent scientific confirmation.

Finding: Bioinformatics and learning identify CDK2 as a cervical-cancer prognostic and apoptotic biomarker. The publisher Methods and Results were checked; this conclusion is limited to the study cohort, reference standard and validation described there.

Technology: Bioinformatics and learning identify CDK2 as a cervical-cancer prognostic and apoptotic biomarker.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Bioinformatics and learning identify CDK2 as a cervical-cancer prognostic and apoptotic biomarker.
Test and result
Publisher Results report the case-specific clinical/scientific outcome and comparisons; claim remains bounded to the reported study.
Limitation / still unknown
Validation design, cohort/reference and reported metrics were checked in the source; no broader clinical claim is made.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://e-century.us/files/ajcr/15/6/ajcr0162724.pdf · https://pubmed.ncbi.nlm.nih.gov/40667555/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.